Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P150041/S007

Vysis CLL Fish Probe Kit

Abbott Molecular, Inc. · Decision date Aug 8, 2025

FDA DECISIONP150041/S007

What did the FDA decide?

FDA records P150041/S007 as a supplement to PMA P150041, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 8, 2025.

FDA approval order statement

manufacturing changes
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Pathology
Decision date
Aug 8, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P150041/S007
Regulatory pathway
PMA supplement
Product code
PNK
Decision code
OK30
Decision date
Aug 8, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Fluorescence In Situ Hybridization, Chromosome 17p Deletion (Tp53).

Product code
PNK
FDA device class
2

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P150041/S007 received

    Application receipt date recorded by FDA.

  2. P150041/S007 · FDA decision

    30-Day Notice

  3. P150041/S008 · Related supplement

    Vysis CLL FISH Probe Kit

Timeline entries are records held by MedtechLedger for P150041. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P150041

Product / regulatory recordCompanyPathwayDecision dateSource
Abbott Molecular, Inc.PMA supplementFeb 18, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Molecular, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1300 E Touhy Ave., Des Plaines, IL, 60018

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records